These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11231377)

  • 1. Parathyroid gland hyperplasia in uremia.
    Drüeke TB
    Kidney Int; 2001 Mar; 59(3):1182-3. PubMed ID: 11231377
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell biology of parathyroid hyperplasia in uremia.
    Fukagawa M
    Am J Med Sci; 1999 Jun; 317(6):377-82. PubMed ID: 10372837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia.
    Szabo A; Merke J; Beier E; Mall G; Ritz E
    Kidney Int; 1989 Apr; 35(4):1049-56. PubMed ID: 2709685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and prevention of morphologic and ultrastructural changes in uremia-induced hyperplastic parathyroid gland.
    Shiizaki K; Hatamura I; Mato M; Nakazawa E; Saji F; Onishi A; Ogura M; Watanabe Y; Kusano E
    Ultrastruct Pathol; 2011 Oct; 35(5):230-8. PubMed ID: 21867406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of uremic ultrafiltrate on the regulation of the parathyroid cell cycle by calcitriol.
    Canalejo A; Almadén Y; De Smet R; Glorieux G; Garfia B; Luque F; Vanholder R; Rodríguez M
    Kidney Int; 2003 Feb; 63(2):732-7. PubMed ID: 12631141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation in hyperplastic human and normal rat parathyroid glands: role of phosphate, calcitriol, and gender.
    Almaden Y; Felsenfeld AJ; Rodriguez M; Cañadillas S; Luque F; Bas A; Bravo J; Torregrosa V; Palma A; Ramos B; Sanchez C; Martin-Malo A; Canalejo A
    Kidney Int; 2003 Dec; 64(6):2311-7. PubMed ID: 14633156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid growth and regression in experimental uremia.
    Taniguchi M; Tokumoto M; Matsuo D; Tsuruya K; Hirakata H; Iida M
    Kidney Int; 2006 Feb; 69(3):464-70. PubMed ID: 16395258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor.
    Ritter CS; Finch JL; Slatopolsky EA; Brown AJ
    Kidney Int; 2001 Nov; 60(5):1737-44. PubMed ID: 11703591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
    J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
    Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
    Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia.
    Basile C; Lomonte C; Vernaglione L; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Cazzato F
    Nephrol Dial Transplant; 2006 Apr; 21(4):968-74. PubMed ID: 16326747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
    Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apoptosis in parathyroid of uremic patients with secondary hyperparathyroidism and the influence of Ca2+ and calcitriol on APO].
    Zhang P; Wei J; Han D
    Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):161-3. PubMed ID: 11798642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.
    Cozzolino M; Lu Y; Finch J; Slatopolsky E; Dusso AS
    Kidney Int; 2001 Dec; 60(6):2109-17. PubMed ID: 11737585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic abnormalities in parathyroid nodules of uremic patients.
    Chudek J; Ritz E; Kovacs G
    Clin Cancer Res; 1998 Jan; 4(1):211-4. PubMed ID: 9516973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism.
    Zhang P; Duchambon P; Gogusev J; Nabarra B; Sarfati E; Bourdeau A; Drüeke TB
    Kidney Int; 2000 Feb; 57(2):437-45. PubMed ID: 10652020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viability and functionality of fresh and cryopreserved human hyperplastic parathyroid tissue tested in vitro.
    Alvarez-Hernández D; González-Suárez I; Carrillo-López N; Naves-Díaz M; Anguita-Velasco J; Cannata-Andía JB
    Am J Nephrol; 2008; 28(1):76-82. PubMed ID: 17914248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.